PF-06463922, soluble in warmed DMSO and warmed ethanol and insoluble in water, is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against ALK. It targets ALK, ROS1, ALK (L1196M), DCAMKL2(DCK2), EGFR(ErbB1)T790M, EGFR(ErbB1)T790ML858R, EPHA1, FER, FES(FPS), FRK(PTK5), and IGF1R.
PF-06463922, also known as lorlatinib, is studied for its effectiveness in overcoming resistance in ALK-positive cancers.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.